Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
07/05/2023 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to Purchase Ordinary Shares | 56.9k | $0.00 | $0 | | 07/05/2023 |
07/05/2023 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to Purchase Ordinary Shares | 45.3k | $0.00 | $0 | | 07/05/2023 |
07/05/2023 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to Purchase Ordinary Shares | 109.7k | $0.00 | $0 | | 07/05/2023 |
07/05/2023 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to Purchase Ordinary Shares | 152.4k | $0.00 | $0 | | 07/05/2023 |
07/05/2023 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to Purchase Ordinary Shares | 73.2k | $0.00 | $0 | | 07/05/2023 |
07/03/2023 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to purchase Ordinary Shares | 500k | $0.00 | $0 | | 07/03/2023 |
06/01/2023 | TCR2 THERAPEUTICS INC. | TCRR | Disposition | Stock Option (Right to Buy) | 16.8k | $0.97 | $16.3k | | 06/01/2023 |
06/01/2023 | TCR2 THERAPEUTICS INC. | TCRR | Disposition | Stock Option (Right to Buy) | 12.1k | $5.21 | $63k | | 06/01/2023 |
06/01/2023 | TCR2 THERAPEUTICS INC. | TCRR | Disposition | Stock Option (Right to Buy) | 12.1k | $31.83 | $385.1k | | 06/01/2023 |
06/01/2023 | TCR2 THERAPEUTICS INC. | TCRR | Disposition | Stock Option (Right to Buy) | 5k | $16.10 | $80.5k | | 06/01/2023 |
06/01/2023 | TCR2 THERAPEUTICS INC. | TCRR | Disposition | Stock Option (Right to Buy) | 6.3k | $16.11 | $101k | | 06/01/2023 |
06/01/2023 | TCR2 THERAPEUTICS INC. | TCRR | Disposition | Stock Option (Right to Buy) | 8.1k | $6.07 | $49k | | 06/01/2023 |
02/02/2023 | Gritstone bio, Inc. | GRTS | Grant | Common Stock | 738.6k | $0.00 | $0 | | 02/02/2023 |
12/15/2022 | TCR2 THERAPEUTICS INC. | TCRR | Grant | Stock Option (Right to Buy) | 16.8k | $0.97 | $16.3k | | 12/15/2022 |
07/01/2022 | Sierra Oncology, Inc. | SRRA | Disposition | Stock Option (right to buy) | 750 | $26.40 | $19.8k | | 07/01/2022 |
07/01/2022 | Sierra Oncology, Inc. | SRRA | Disposition | Stock Option (right to buy) | 1.2k | $76.80 | $96k | | 07/01/2022 |
07/01/2022 | Sierra Oncology, Inc. | SRRA | Disposition | Stock Option (right to buy) | 625 | $130.80 | $81.8k | | 07/01/2022 |
07/01/2022 | Sierra Oncology, Inc. | SRRA | Disposition | Stock Option (right to buy) | 12k | $13.98 | $168.2k | | 07/01/2022 |
07/01/2022 | Sierra Oncology, Inc. | SRRA | Disposition | Stock Option (right to buy) | 6k | $18.11 | $108.7k | | 07/01/2022 |
07/01/2022 | Sierra Oncology, Inc. | SRRA | Disposition | Common Stock | 1.6k | $55.00 | $90.8k | | 07/01/2022 |
01/31/2022 | Gritstone bio, Inc. | GRTS | Grant | Common Stock | 70k | $0.00 | $0 | | 01/31/2022 |
01/31/2022 | Gritstone bio, Inc. | GRTS | Grant | Stock Option (Right to Buy) | 410k | $5.46 | $2.2M | | 01/31/2022 |
12/09/2021 | TCR2 THERAPEUTICS INC. | TCRR | Grant | Stock Option (Right to Buy) | 12.1k | $5.21 | $63k | | 12/09/2021 |
06/11/2021 | Epizyme, Inc. | EPZM | Grant | Stock Option (Right to Buy) | 40.6k | $8.53 | $346k | | 06/11/2021 |
06/11/2021 | Epizyme, Inc. | EPZM | Grant | Common Stock, par value $0.0001 | 8.1k | $0.00 | $0 | | 06/11/2021 |
06/08/2021 | Sierra Oncology, Inc. | SRRA | Grant | Stock Option (Right To Buy) | 6k | $18.11 | $108.7k | | 06/08/2021 |
03/08/2021 | Gritstone bio, Inc. | GRTS | Grant | Stock Option (Right to Buy) | 290k | $13.87 | $4M | | 03/08/2021 |
01/07/2021 | Gritstone bio, Inc. | GRTS | Grant | Common Stock | 48.2k | $0.00 | $0 | | 01/07/2021 |
12/10/2020 | TCR2 THERAPEUTICS INC. | TCRR | Grant | Stock Option (Right to Buy) | 12.1k | $31.83 | $385.1k | | 12/10/2020 |
06/09/2020 | Sierra Oncology, Inc. | SRRA | Grant | Stock Option (right to buy) | 12k | $13.98 | $168.2k | | 06/09/2020 |
05/29/2020 | Epizyme, Inc. | EPZM | Grant | Stock Option (Right to Buy) | 14k | $17.55 | $245.9k | | 05/29/2020 |
03/16/2020 | Epizyme, Inc. | EPZM | Exercise | Stock Option (Right to Buy) | 12.5k | $9.33 | $116.6k | | 03/16/2020 |
12/19/2019 | TCR2 THERAPEUTICS INC. | TCRR | Grant | Stock Option (Right to Buy) | 5k | $16.10 | $80.5k | | 12/19/2019 |
06/11/2019 | Sierra Oncology, Inc. | SRRA | Grant | Stock Option (right to buy) | 30k | $0.66 | $19.8k | | 06/11/2019 |
05/31/2019 | Epizyme, Inc. | EPZM | Grant | Stock Option (Right to Buy) | 17.6k | $13.74 | $242.3k | | 05/31/2019 |
|